Blog
Insights on using AI to search for the cure of cancer

In today's fast-paced world, keeping up with the latest developments in cancer research can be a daunting task. With an overwhelming amount of information available, it’s easy for patients,...
Read more →
In a significant breakthrough for blood cancer treatment, scientists at The University of Texas MD Anderson Cancer Center have developed a first-in-class therapy targeting the notoriously elusive MYC...
Read more →
Celebrating Excellence in Cancer Research: The Impact of UT MD Anderson's Faculty Awards
August 22, 2026
The recent Faculty Excellence Awards at the University of Texas MD Anderson Cancer Center have spotlighted some of the most dedicated and innovative minds in the battle against cancer. Held on August...
Read more →
Discover Cure Cancer With AI: Your Comprehensive Resource for Cancer Research and Insights
August 22, 2026
Cancer is an ever-evolving field, with new research, clinical trials, and treatment options emerging daily. For patients, caregivers, and advocates, keeping up with the latest developments can often...
Read more →
Celebrating Excellence in Cancer Research: The Role of AI in Advancing Treatment Innovation
August 22, 2026
On August 20, 2026, the University of Texas MD Anderson Cancer Center honored its top faculty members during the annual Faculty Excellence Awards. This event celebrated the exceptional contributions...
Read more →
Unlocking the Secrets of Gene Activation: How AI Is Paving the Way for Cancer Research
August 22, 2026
In a groundbreaking study published recently, researchers have employed artificial intelligence (AI) to decode a vital DNA sequence known as the "initiator," which plays a crucial role in gene...
Read more →
At Cure Cancer With AI, our mission is to empower individuals and families affected by cancer through education and awareness of the latest advancements in cancer research and artificial...
Read more →
In a significant leap for cancer research, scientists have recently decoded a critical DNA sequence known as the "initiator," which is pivotal in the regulation of gene activation. This...
Read more →
Groundbreaking Therapy Offers New Hope for Hard-to-Treat Blood Cancers by Targeting the MYC Protein
August 22, 2026
Recent research from The University of Texas MD Anderson Cancer Center has unveiled a promising first-in-class therapy that targets the MYC protein, a notorious challenge in cancer treatment. This...
Read more →
At Cure Cancer With AI , we believe that knowledge is power. Our mission is to empower individuals with the latest information on cancer research, the role of artificial intelligence in oncology, and...
Read more →
In a promising development for cancer patients and the research community, researchers at the University of Michigan have discovered a novel approach to treating advanced prostate cancer that has...
Read more →
Breakthrough in Treating Advanced Prostate Cancer: New Drug Combination Targets Challenging Tumor Pathways
August 21, 2026
Recent findings from researchers at the University of Michigan have illuminated a promising pathway in the fight against advanced prostate cancer, particularly for a subtype known as...
Read more →
Navigating the vast and complex landscape of cancer research, clinical trials, and treatment options can often feel overwhelming for patients, caregivers, and advocates alike. With so much...
Read more →
In a significant breakthrough for the oncology community, researchers in Australia have identified a molecular switch that plays a crucial role in the aggressiveness of triple-negative breast cancer...
Read more →
New ACCESS Trial Findings Revolutionize Stem Cell Donor Selection for Blood Cancer Patients
August 21, 2026
The recent findings from the ACCESS trial, published in Blood Advances, are a game-changer for patients battling blood cancers who require stem cell transplants. Traditionally, the search for a...
Read more →
At Cure Cancer With AI, our mission extends beyond providing valuable information and resources about cancer research and advancements in oncology. We strive to empower individuals with the knowledge...
Read more →
The landscape of blood cancer treatment is evolving, with recent findings from the ACCESS trial shedding light on the potential for broader stem cell donor options. This groundbreaking research...
Read more →
Promising Chemotherapy-Free Treatment for Metastatic Breast Cancer: A Breakthrough from Mount Sinai
August 21, 2026
In a recent study conducted by researchers at the Icahn School of Medicine at Mount Sinai, a groundbreaking approach to treating HR-positive, HER2-positive metastatic breast cancer has emerged. This...
Read more →
The landscape of cancer research is continuously evolving, with new studies, clinical trials, and treatment modalities emerging regularly. For patients, caregivers, advocates, and anyone interested...
Read more →
New mRNA Platform Offers Hope for Faster Cancer Treatments: What This Means for Patients
August 20, 2026
Recent advancements in cancer research have taken a significant leap forward with an experimental mRNA-based platform developed by scientists at Johns Hopkins Medicine. This innovative technology...
Read more →